Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  5/8/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 5/8/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  5/8/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 5/8/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  5/8/2017
Great Lakes Gastroenterology Research
mi
from
Mentor, OH
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 5/8/2017
Great Lakes Gastroenterology Research
mi
from
Mentor, OH
Click here to add this to my saved trials
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  5/8/2017
University of Pennsylvania - Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 5/8/2017
University of Pennsylvania - Perelman Center for Advanced Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  5/8/2017
Vanderbilt University
mi
from
Nashville, TN
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 5/8/2017
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  5/8/2017
University of Utah Division of Gastroenterology
mi
from
Salt Lake City, UT
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 5/8/2017
University of Utah Division of Gastroenterology
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  5/8/2017
Gastrointestinal Research Group, University of Calgary Health
mi
from
Calgary,
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
A Phase2, Multi-Center, Multi-national, Randomized, Double-blind, Placebo-controlled Parallel-group Clinical Trial to Evaluate the Efficacy and Safety of RPC4046 in Adult Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 5/8/2017
Gastrointestinal Research Group, University of Calgary Health
mi
from
Calgary,
Click here to add this to my saved trials
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
Addition of a Probiotic (Lactobacillus GG) to Metronidazole for the Treatment of Clostridium Difficile Associated Disease
Status: Enrolling
Updated:  5/9/2017
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Addition of Lactobacillus to Metronidazole in Treatment of CDAD
Addition of a Probiotic (Lactobacillus GG) to Metronidazole for the Treatment of Clostridium Difficile Associated Disease
Status: Enrolling
Updated: 5/9/2017
Michael E. DeBakey Veterans Affairs Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy Of Ergocalciferol In Adults According To BMI
Efficacy Of Ergocalciferol In Adults According To BMI
Status: Enrolling
Updated:  5/10/2017
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Efficacy Of Ergocalciferol In Adults According To BMI
Efficacy Of Ergocalciferol In Adults According To BMI
Status: Enrolling
Updated: 5/10/2017
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Patient Preferences of a Resect and Discard Paradigm
Patient Preferences of a Resect and Discard Paradigm
Status: Enrolling
Updated:  5/10/2017
Washington University in St. Louis
mi
from
Saint Louis, MO
Patient Preferences of a Resect and Discard Paradigm
Patient Preferences of a Resect and Discard Paradigm
Status: Enrolling
Updated: 5/10/2017
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Prevalence of Dysplasia of the Gastric Cardia
Prevalence of Dysplasia of the Gastric Cardia
Status: Enrolling
Updated:  5/15/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Prevalence of Dysplasia of the Gastric Cardia
Prevalence of Dysplasia of the Gastric Cardia
Status: Enrolling
Updated: 5/15/2017
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated:  5/15/2017
Division of Gastroenterology, Mt. Sinai Medical Center
mi
from
Miami Beach, FL
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated: 5/15/2017
Division of Gastroenterology, Mt. Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated:  5/15/2017
Mt. Sinai Medical Center, Division of Gastroenterology
mi
from
Miami Beach, FL
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated: 5/15/2017
Mt. Sinai Medical Center, Division of Gastroenterology
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated:  5/15/2017
Mt. Sinai Medical Center, Division of Gastroenterology
mi
from
Miami Beach, FL
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
Clinical Applications of Domperidone in Patients With Refractory Gastroesophageal Reflux Disease or Delayed Gastric Solid-Phase Emptying
Status: Enrolling
Updated: 5/15/2017
Mt. Sinai Medical Center, Division of Gastroenterology
mi
from
Miami Beach, FL
Click here to add this to my saved trials
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated:  5/15/2017
Site US116
mi
from
Madison, WI
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated: 5/15/2017
Site US116
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated:  5/15/2017
Site CA00203
mi
from
Toronto,
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
An Open-Label Phase 2 Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Status: Enrolling
Updated: 5/15/2017
Site CA00203
mi
from
Toronto,
Click here to add this to my saved trials
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated:  5/16/2017
University of Maryland
mi
from
Baltimore, MD
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated: 5/16/2017
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Comprehensive Clinical Research
mi
from
Berlin, NJ
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Comprehensive Clinical Research
mi
from
Berlin, NJ
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
QPharm Pty Limited
mi
from
Herston,
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
QPharm Pty Limited
mi
from
Herston,
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
Tampa General Hospital
mi
from
Tampa, FL
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
North Shore - Long Island Jewish Health System
mi
from
Lake Success, NY
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
St. Francis Hospital
mi
from
Roslyn, NY
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
St. Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
Yale New-Haven Medical Center
mi
from
New Haven, CT
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
Yale New-Haven Medical Center
mi
from
New Haven, CT
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
Northwestern Memorial Hospital
mi
from
Chicago, IL
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
Tufts Medical Center
mi
from
Boston, MA
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
Case Medical Center
mi
from
Cleveland, OH
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated:  5/22/2017
Catholic University of Sacred Heart
mi
from
Rome,
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy
Status: Enrolling
Updated: 5/22/2017
Catholic University of Sacred Heart
mi
from
Rome,
Click here to add this to my saved trials
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated:  5/22/2017
Presbyterian University Hospital of UPMC
mi
from
Pittsburgh, PA
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated: 5/22/2017
Presbyterian University Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated:  5/22/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated: 5/22/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer
Assessing the Clinical Significance of Real-time Quality of Life Data in Cancer Patients Treated With Radiation Therapy
Status: Enrolling
Updated:  5/23/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer
Assessing the Clinical Significance of Real-time Quality of Life Data in Cancer Patients Treated With Radiation Therapy
Status: Enrolling
Updated: 5/23/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
Calprotectin-Directed Humira® Maintenance Therapy, a Double-blind, Double-dummy, Randomized Controlled Trial in Crohn's Disease
Status: Enrolling
Updated:  5/23/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)
Calprotectin-Directed Humira® Maintenance Therapy, a Double-blind, Double-dummy, Randomized Controlled Trial in Crohn's Disease
Status: Enrolling
Updated: 5/23/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis
Should Elective Resection Follow Nonoperative Management of First Episode of Diverticulitis of the Colon With Abscess and/or Extraluminal Air? A Randomized Controlled Trial.
Status: Enrolling
Updated:  5/26/2017
Stony Brook Medicine
mi
from
Stony Brook, NY
Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis
Should Elective Resection Follow Nonoperative Management of First Episode of Diverticulitis of the Colon With Abscess and/or Extraluminal Air? A Randomized Controlled Trial.
Status: Enrolling
Updated: 5/26/2017
Stony Brook Medicine
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
Status: Enrolling
Updated:  5/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
Status: Enrolling
Updated: 5/30/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Anaheim, CA
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Bristol, CT
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Bristol, CT
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Owensboro, KY
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Chevy Chase, MD
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Towson, MD
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Towson, MD
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Chesterfield, MI
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Chesterfield, MI
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Great Neck, NY
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
New York, NY
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Raleigh, NC
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Beavercreek, OH
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Beavercreek, OH
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Columbus, OH
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Oklahoma City, OK
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated:  5/31/2017
GSK Investigational Site
mi
from
Jackson, TN
A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis
Status: Enrolling
Updated: 5/31/2017
GSK Investigational Site
mi
from
Jackson, TN
Click here to add this to my saved trials